Marcus Boehm

Marcus Boehm (board member) discloses dealings in Vyant Bio, Inc. to SEC (Form 4). Over a trading history stretching from 30 March 2021 to 18 April 2022, the count stands at 11 filings.

Every open-market trade on record is a purchase: 6 purchases worth €65k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 3 share grants.

Half of the purchases are above €11k and half below. On 3 out of 6 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 19 April 2022, the filings show a share grant in Vyant Bio, Inc. The clock since the last published purchase (7 December 2021) now reads 1,776 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.